Onconaut Therapeutics Inc.
Onconaut Therapeutics Inc.
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Employment
  • More
    • Home
    • About
    • Science
    • Pipeline
    • News
    • Contact
    • Employment
  • Home
  • About
  • Science
  • Pipeline
  • News
  • Contact
  • Employment

About

The Onconaut Team

Dan LaBarbera, PhD

Founder, Chief Executive Officer

Professor and Director 

CU Anschutz Center for 

Drug Discovery 

Linkedin

Neal Goodwin, PhD

Chief Science Officer 

Former VP of R&D Campions Oncology 

Former Director of R&D Jackson Laboratory

Former CSO ProNAi Therapeutics now Sierra Oncology

Linkedin

Tony Piscopio, PhD

Head of Medicinal Chemistry 

& Scientific Advisor

Formerly with Amgen & Pfizer

Founder & Former Executive Array

Founder & Former CEO OnKure

Linkedin

RICH WOESSNER, PHD


 Head of Pharmacology 

&  Scientific Advisor

Formerly with Array Biopharma & OnKure Therapeutics

Linkedin

Joanna Money, PhD

  Chief Business Officer 

  Client Director at Innosphere Ventures 


LinkedIn

Gavin Maitland

 Chief Financial Officer

Fleming CFO Inc.



LinkedIn

Advisors & Consultants

NICK SACCOMANO, PHD

  Scientific Advisor 

Former Executive Pfizer & Array 

Current CEO OnKure

LinkedIn

CHRISTOPHER Lieu, MD

Medical Oncology & Clinical Advisor

CU Cancer Center & UC Health

CU Cancer Center

Steve Haney, PhD

Preclinical Drug Discovery and Development Consultant

Formerly with Pfizer, Eli Lilly & Wyeth

LinkedIn

ROBERT HARGREAVES, PHD

 Regulatory Preclinical &

CMC Consultant & Principal at R3LS

LinkedIn

Copyright © 2025 Onconaut Therapeutics Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept